Dr. Raza and Dr. Ali will focus on developing new strategies to target tumor macrophage hybrid cells in order to prevent cancer metastasis and overcome resistance to traditional cancer therapies.
Four teams of researchers at Columbia University have been awarded 2023 Edward P. Evans Center for Myelodysplastic Syndromes (MDS) Pilot Awards and Fellowships
Researchers at Columbia have begun a clinical trial to assess the feasibility of using focused ultrasound to facilitate the delivery of chemotherapy to progressive diffuse intrinsic pontine gliomas.
Using a clever combination of new computer algorithms and cell culture techniques, scientists at the HICCC have addressed a question that’s long troubled cancer researchers.
A new three-year, $2.5 million grant from Stand Up to Cancer (SU2C) has been awarded to a multi-institutional team of gastroesophageal cancer experts, led by HICCC director Anil K. Rustgi, MD.
